IBS' Proprietary Sequencing Technology
featured in NHGRI Conference . IBS'
CEO, Dr. Steven Gordon described some of the company's innovative
technology from NIH grants in a public forum in San Diego. March 18, 2011
IBS's New Diagnostic Sequencing System
Unveiled during XGEN Conference. Dr.
Gordon presents the unique features of IBS's new MINI sequencer. September 14, 2010
IBS is Awarded $2.6M
NIH Grant - for development of "Third Generation DNA
Sequencing Technology." More News and More Details
Intelligent Bio-Systems
Introducing MaxSeq
Sequencer and Early Access Program for the MINI Sequencer!
Buy a MaxSeq
ultra-high-throughput DNA sequencing
system
now.
IBS is also currently enrolling customers for an early version of its
MINI clinical sequencing
instrument featuring 20 independent sample runs with random access. Contact
IBS
for details.
The
IBS
Team.
Intelligent
Bio-Systems is a group of innovative and experienced chemists,
molecular biologists and engineers capable of bringing breakthrough
technologies to market quickly. Click here for a list of
open
positions at the company. About Us
Intelligent
Bio-Systems
was
founded
in
2005
by
Drs. Steven J. Gordon and
Jingyue Ju to commercialize an advanced DNA sequencing system. Dr.
Gordon
previously founded Intelligent Automation Systems, which was
responsible for a
number of key instrumentation solutions which helped to complete the
Human Genome Project. Dr. Ju is one of the key inventors of fluorescent
energy
transfer dyes used in most electrophoresis-based sequencers.
Licensing Partner
Intelligent Bio-Systems is the exclusive licensee of Columbia
University's sequencing by synthesis patent portfolio invented by Dr.
Jingyue
Ju
